Home
Dashboard
Bookmarks
Portfolios
ExplorerFunds
Equities
Library
Insights
Pinindices
MobileApp Store
Android

India

South-East Asia - Conglomerates and SpecialistsEconomic growth in the world's most populous countries (ex-China) brings the potential of home-grown conglomerates and specialized industries into focus
South-East Asia - Conglomerates and Specialists
  • 5.5%
  • 15
Pharma GenericsNew opportunities or an uncertain future ?
Pharma Generics
  • 0.8%
  • 8
  • 1
Leveraged Emerging Markets (ex. China)Attraction of emerging markets parting ways with China
Leveraged Emerging Markets (ex. China)
  • 81.9%
  • 6
India ETFsThe Indian economy is expected to grow strongly in 2023 and 2024
India ETFs
  • -6.3%
  • 12
  • 2
Vaccines markets are collaborative and competitiveWith just 4 major pharmaceutical companies in the lead and 2 powerful mRNA newcomers
Vaccines markets are collaborative and competitive
  • 30.0%
  • 12
  • 5
Indian Companies - U.S. listingsList of shares traded - Variable trading volumes will alter true performance and volatility ratios
Indian Companies - U.S. listings
  • 11.3%
  • 14
  • 8